-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614.P1.41 614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Terry J. Fry, M.D.1, Maryalice Stetler-Stevenson, MD, PhD2, Nirali N Shah, MD1, Constance M. Yuan, MD, PhD2*, Bonnie Yates, RN, PNP3*, Cindy Delbrook, RN3*, Ling Zhang, Ph.D.3*, Daniel W. Lee III, MD1, David Stroncek, MD4 and Crystal L. Mackall, MD3

1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Pathology, National Cancer Institute, Bethesda, MD
3Pediatric Oncology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD
4Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD

Jae-Woong Lee, PHD1*, Huimin Geng, PhD2*, Zhengshan Chen, MD PhD1*, Eugene PARK, PHD1*, Lars Klemm, BSc, MSc3*, Charles C. Bailey4* and Markus Muschen, MD, PhD1

1Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
2Laboratory Medicine, University of California, San Francisco, San Francisco, CA
3University of California San Francisco, San Francisco, CA
4Department of Microbiology and Immunobiology, Harvard Medical School, Southborough, MA

Adrian Schwarzer, MD, PhD1,2*, Martin May3*, Harald Genth3*, Zhixiong Li, MD4, Christopher Baum, MD5 and Axel Schambach, MD, PhD1,6*

1Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
2Department of Hematology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
3Institute of Toxicology, Hannover Medical School, Hannover, Germany
4Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Hannover Medical School, Institute of Experimental Hematology, Hannover, Germany
6Division of Hematology/Oncology, Harvard Medical School, Boston

Gilles M. Leclerc, PhD1*, Shuhua Zheng, BS2, Guy J. Leclerc, Ph.D.1*, Joanna DeSalvo, BSc1*, Ronan T. Swords, MD, PhD, FRCPI, FRCPath3 and Julio C. Barredo, M.D.1

1Pediatrics Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL
2The Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL
3Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Hospitals, Miami, FL

Amir T Fathi, MD1, Uma Borate, MD2, Daniel J. DeAngelo, MD, PhD3, Maureen M. O'Brien, MD4, Tanya Trippett, MD5*, Bijal D Shah6, Gregory A. Hale, MD7, James M. Foran, MD8, Lewis B. Silverman, MD9, Raoul Tibes, MD, PhD10, Stuart Cramer, D.O.11*, Melinda Pauly, MD12*, Stella Kim13*, Ana Kostic, MD14, Xiaohui Huang14*, Yang Pan, PhD14* and Robert Chen15

1Massachusetts General Hospital/Harvard Medical School, Boston, MA
2University of Alabama at Birmingham, Birmingham, AL
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Memorial Sloan Kettering Cancer Cent., New York, NY
6H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7All Children’s Hospital/Johns Hopkins University, St. Petersburg, FL
8Mayo Clinic Cancer Center, Jacksonville, FL
9Pediatric Oncology, Dana Farber Cancer Institute/Boston Children’s Hospital, Boston, MA
10Mayo Clinic Arizona, Scottsdale, AZ
11University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL
12Children’s Healthcare of Atlanta at Egleston, Atlanta, GA
13Cizik Eye Clinic, Houston, TX
14Seattle Genetics, Inc., Bothell, WA
15City of Hope National Medical Center, Duarte, CA

Jessica Leonard, MD1, Joelle Rowley2*, Brandon Hayes-Lattin, MD3, Jeffrey W. Tyner, PhD4, Marc Loriaux, MD, PhD5*, Brian J. Druker, MD5 and Bill H Chang, MD, PhD4

1Oregon Health and Science University, Portland, OR
2Oregon Health & Science University, Portland, OR
3Oregon Health Science University, Portland, OR
4Knight Cancer Institute, Oregon Health & Science University, Portland, OR
5Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

Emilee Senkevitch, PhD, BS1, Julie Hixon1*, Caroline Andrews1*, Joao T Barata, PhD2*, Wenqing Li1* and Scott Durum1*

1Cancer and Inflammation Program, National Cancer Institute, Frederick, MD
2Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal

Takanobu Morishita, MD1*, Fumihiko Hayakawa, MD, PhD1*, Keiki Sugimoto, PhD2*, Daiki Hirano, MD1*, Yuki Kojima, MD1*, Naoto Imoto, MD3*, Yuichiro Inagaki, MD4*, Tomoki Naoe, MD, PhD5 and Hitoshi Kiyoi, MD, PhD1

1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Fujii Memorial Research Institute, Otsuka Pharmaceutical Co. Ltd., Otsu, Japan
3Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan
4Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
5National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Fabian Mueller, MD, PhD1*, Xiu-Fen Liu, Ph.D.1*, Alan S. Wayne, MD2 and Ira Pastan, MD3*

1NCI/CCR/LMB, National Institutes of Health, Bethesda, MD
2Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
3Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Josep-Maria Ribera, MD, PhD1, Mireia Morgades, MD1*, Juana Ciudad, MD, PhD2*, Pere Barba, MD, PhD3*, Rodrigo Martino, MD, PhD4, Pau Montesinos, MD, PhD5*, Susana Vives6*, MªJosé Moreno, MD7*, Beatriz Soria, MD8*, Cristina Gil, MD9*, José González-Campos, MD10*, MªLuz Amigo, MD11*, Andrés Novo, MD12*, Mar Tormo, MD, PhD13, Arancha Bermúdez, MD14*, Alfons Serrano, MD15*, Teresa Bernal, MD16*, Aurelio López17*, Juan Bergua18*, Lourdes Escoda, MD, PhD19*, Pilar Martínez, MD20*, Natalia Alonso, MD21*, Santiago Mercadal, MD22*, Eugenia Abella, MD, PhD23*, Ramon Guàrdia, MD, PhD24*, Ferran Vall-llovera, MD25*, Antònia Cladera, MD26*, Jordi Esteve, MD, PhD27, Raimundo García-Boyero, MD28*, Evarist Feliu, MD, PhD29* and Alberto Orfao, MD, PhD2

1Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
2Centro de Investigación del Cáncer (CIC, IBMCC USAL-CSIC), Servicio General de Citometría, Universidad de Salamanca, Salamanca, Spain
3Department of Hematology, Hospital Vall d'Hebron, Barcelona, Spain
4Hospital Santa Creu i Sant Pau, Barcelona, Spain
5Hospital Universitario La Fe, Valencia, Spain
6Hospital Universitari Germans Trias i Pujol, Badalona, Spain
7Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
8Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
9Hospital General de Alicante, Alicante, Spain
10Hospital Universitario Virgen del Rocío, Sevilla, Spain
11Hospital Morales Meseguer, Murcia, Spain
12Hospital Son Espases, Palma de Mallorca, Spain
13Hospital Clínico Universitario de Valencia, Valencia, Spain
14Hospital Universitario Marqués de Valdecilla, Santander, Spain
15Hospital Madrid Sanchinarro, Madrid, Spain
16Hospital Universitario Central de Asturias, Oviedo, Spain
17Hospital Arnau de Vilanova, Valencia, Spain
18Hospital San Pedro de Alcántara, Cáceres, Spain
19ICO-Hospital Joan XXIII, Tarragona, Spain
20Hospital Universitario Doce de Octubre, Madrid, Spain
21Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
22ICO-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain
23Hospital del Mar, Barcelona, Spain
24ICO- Hospital Josep Trueta, Girona, Spain
25Hospital Universitari Mutua Terrassa, Terrassa, Spain
26Hospital Son Llàtzer, Palma de Mallorca, Spain
27Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
28Hospital Universitario General de Castellón, Castellón de la Plana, Spain
29Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain

David T Teachey, MD1,2, Simon F. Lacey, PhD, BSc3*, Pamela A Shaw, PhD4*, J Joseph Melenhorst, PhD5*, Noelle V. Frey, MD6, Shannon L Maude, MD, PhD1,2, David M. Barrett, MD, PhD1,7*, Richard Aplenc, MD, PhD1,2, Fang Chen, Ph.D.3*, Julie Fitzgerald, MD, PhD8,9*, Vanessa Gonzalez, M.B.A3*, Edward Pequignot, Ph.D.3*, Susan R. Rheingold, MD1,2, Scott Weiss, MD8,9*, Jason C. White, DO10*, Carl H. June, MD5,11, David L. Porter, MD12 and Stephan A. Grupp, MD, PhD1,2

1Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Translational and Correlational Studies Laboratory, University of Pennsylvania, Philadelphia, PA
4Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
5Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
6Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
7Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
8University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
9Children's Hospital of Philadelphia, Philadelphia, PA
10Fort Belvoir Community Hospital, Fort Belvoir, VA
11Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
12Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Jenny Dahl, PA1*, Hagop M. Kantarjian, MD2, Musa Yilmaz, MD3*, Tapan Kadia, MD2, Guillermo Garcia-Manero, MD4, Farhad Ravandi, MD2, Gautam Borthakur, MD2, Jorge E. Cortes, MD5, Alessandra Ferrajoli, MD2, Koji Sasaki, MD2, Jad Chahoud, MD1*, Jane Autry, RN1*, Rebecca Garris2* and Elias Jabbour2

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematology & Oncology, Baylor College of Medicine, Houston, TX
4Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH